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ABSTRACT 1 
Two-point discrimination is measured as an indicator of cortical reorganisation in 2 
musculoskeletal medicine. Nevertheless, data are lacking for the reliability of this measure in 3 
patients with non-specific chronic low back pain (NSCLBP). We aimed to quantify the intra- 4 
and inter-observer reliability of a novel protocol for measuring two-point discrimination in 5 
these patients. 35 participants (12 males, 23 females, mean age 52, SD 15years) with 6 
NSCLBP were recruited. Three clinicians made 14 consecutive measurements of two-point 7 
discrimination with callipers. One of these clinicians repeated the assessment protocol within 8 
7 days. During each measurement, the calliper width was widened in 5-mm increments until 9 
participants could consistently identify two points. Intra- and inter-observer agreement was 10 
quantified using mean difference, within-subject SD and limits of agreement (LOA). After 11 
using the first measurement for familiarisation, the mean of measurements 2 to 5 within an 12 
assessment resulted in the optimum compromise between clinic time constraints and 13 
acceptable intra-observer reliability; the within-subjects SD being 7.5 mm (LOA: 20.8 mm). 14 
Inter-observer reliability was generally poorer; requiring the mean of measurements 2 to 9 15 
within an assessment for a similar within-subjects SD of 8.6 mm (LOA: 23.7 mm). It was 16 
estimated that these within-subjects SDs were small enough for a clinically-important change 17 
to be detected with a feasible sample size in future studies. The intra-observer reliability of 18 
our assessment protocol is acceptable for detecting a clinically relevant difference in two-19 
point discrimination for future research purposes. Nevertheless, individual patient 20 
measurement variability is relatively high, especially between different clinicians. 21 
Key words: Tactile acuity, reliability, low back pain, measurement 22 
23 
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INTRODUCTION 1 
It has been reported that the somatosensory cortex is disrupted in patients with chronic pain - 2 
a phenomenon termed cortical reorganisation [1]. In patients with phantom limb pain and 3 
complex regional pain syndrome, the degree of cortical reorganisation has been shown to 4 
directly relate to their pain experience [2] and, as the pain intensity improves, the 5 
somatosensory representation normalises [3]. While the mechanisms have not been fully 6 
elucidated, normalisation of the somatosensory cortex is considered a viable target for the 7 
treatment for pain patients [4]. Interventions attempting to normalise cortical reorganisation, 8 
such as sensory discrimination training [5], have provided preliminary proof-of-concept for 9 
such interventions.  10 
 11 
Cortical reorganisation has been shown in patients with non-specific chronic low back pain 12 
(NSCLBP) [6].  Furthermore, preliminary studies targeted at cortical reorganisation in 13 
patients with NSCLBP have shown promising results [5, 7]. As interventions that target 14 
cortical reorganisation for patients with NSCLBP become more common in clinical practice 15 
and research, there is a need to ensure that cortical reorganisation can be measured reliably 16 
and efficiently. The gold standard methods of measuring cortical reorganisation are functional 17 
Magnetic Resonance Imaging (fMRI) and Electromagnetic Encephalography (EEG) [8]. 18 
These methods are very expensive, require sophisticated technology, skilled technicians and 19 
can be time consuming. Therefore, there is a need to develop and appraise less expensive 20 
assessment methods, which also have acceptable clinical utility. 21 
 22 
Two-point discrimination (TPD) is a simple clinical test of tactile acuity, which measures the 23 
minimum distance between two points on the skin that can be consciously detected [9]. 24 
Smaller distances indicate better acuity. Because TPD is correlated with cortical 25 
reorganisation, it is commonly-used as a proxy measure of cortical reorganisation [10]. TPD 26 
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was initially developed to assess finger and hand tactile acuity [11]. More recently, studies 1 
have used TPD to asses lower back tactile acuity as a proxy measure of lower back 2 
somatosensory reorganisation [12, 13]. To date, only one research group has investigated the 3 
reliability of lower back TPD and these researchers studied asymptomatic individuals [14]. 4 
Given that the test will be used clinically in patients with non-specific CLPB, there is a need 5 
to directly assess the reliability of this technique in that population.  6 
 7 
It has been highlighted that current TPD techniques involve a considerable amount of 8 
subjectivity, where the clinician must make a judgement as to when sufficient consistency of 9 
distance has been attained [15]. This can be clinically challenging, time consuming and can 10 
introduce bias. There is a need to develop a TPD protocol, which reduces this source of 11 
variability by minimising clinician judgment. The overarching aim of this study was to 12 
develop and quantify the intra- and inter-observer reliability of a novel lower back TPD 13 
assessment protocol, which minimises subjective clinical judgement, in patients with 14 
NSCLBP. Specifically, the two objectives were to establish: 15 
 16 
1. the minimum number of TPD measurements required within the assessment protocol 17 
to maximise intra-observer reliability whilst minimising the time required to complete 18 
the test; 19 
2. the minimum number of TPD measurements required within the assessment protocol 20 
to maximise inter-observer reliability whilst minimising the time required to complete 21 
the test. 22 
 23 
 24 
 25 
 26 
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METHODS 1 
Study overview 2 
In this reliability study, 35 participants with NSCLBP underwent the same TPD test protocol 3 
at three different time points to assess tactile acuity of the lower back. To assess intra-4 
observer reliability, assessor 1 measured TPD on day 1 and day 2. To assess inter-observer 5 
reliability, a second assessor measured each participant on day 1 and this was compared to the 6 
first assessor’s measurement for day 1. 7 
 8 
Recruitment 9 
Patients were recruited consecutively from physiotherapy practices in Bochum, Germany 10 
between June 2013 and December 2014. Participants had to meet the following inclusion 11 
criteria: age ≥ 18 years; NSCLBP with or without leg pain ( for those with leg pain, the back 12 
pain had to be dominant); duration of symptoms ≥ 6 months; sufficient cognitive and German 13 
language skills/ability to understand both oral and written instructions and to give informed 14 
consent;  intact skin on the lower back. Participants were excluded if they had signs and 15 
symptoms indicating serious spinal pathologies (red flags). The study was approved by 16 
Teesside University’s School of Health and Social Care Research Governance and Ethics 17 
Board and the Ethics committee of the German National Physiotherapists Society. 18 
 19 
Two-Point Discrimination Assessment Procedure 20 
The test procedure was developed from previous protocols for TPD threshold measurement 21 
[16, 17].  Participants were positioned in a comfortable lying prone position on a treatment 22 
bench with their back exposed. A pillow was positioned under the stomach to flatten the 23 
lumbar spine. Feet were supported by a half roll for participant comfort. Using the 24 
standardised palpation procedure according to Merz et al. [18], the tips of the transverse 25 
processes of L5 were located and marked with a washable pen. The measurement tool was a 26 
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2-point discrimination caliper (Nexgen Medical Systems, Florida, USA) with a 1mm 1 
precision. The calliper was applied, a sufficient amount of time to bring about the first 2 
blanching of the skin and was then removed, no more than 1-2 seconds. The calliper was 3 
placed horizontally to the spine and the transverse process of L5 was the center for the 4 
calliper. Testing was carried out in an ascending (or widening) manner, starting with a 5 
distance of 20mm between the two calipers and was increased in 5mm increments. This was 6 
based upon preliminary rehearsals of process which found 1mm increments too time 7 
consuming and distances between 0-20mm being constantly identified as one point. The time 8 
between each increment was no more than a few seconds. The assessment was carried out at 9 
one location of the lower back, either on the affected side or, with bilateral pain, on a prior 10 
randomly identified side. Participants were advised to say ‘one’, when they felt one point and 11 
‘two’ when they felt two points. Catch trials were also included approximately every 5 12 
measurements by either using only one point or the widest possible distance. The distance at 13 
which the participant first identified two points was noted. The callipers were then increased 14 
by 5mm. If the participant again noted two points, this was considered to indicate consistency 15 
of identification and the first distance of two-point identification was taken as the TPD result. 16 
If, however, the participant did not identify the stimulus as two separate points after the 5mm 17 
increment, the assessor continued to expand the distance until two consecutive correct ratings 18 
were provided by the participant. This test procedure, operationally defined within this paper 19 
as a measurement, was performed 14 times consecutively within each TPD assessment, with 20 
the first test considered a practice. The decision to consider the first test as a practice was 21 
based upon evidence of systematic effects, in that the first test was consistently poorer (a 22 
wider TPD score) than subsequent measurements. After discarding the first test, we did not 23 
find any clinically important upward or downward trend amongst the remaining 24 
measurements. 25 
 26 
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Order of testing 1 
One assessor (KE) carried out the TPD protocol with each participant on two separate days. 2 
Day 1 and day 2 were never more than one week apart. Results between day 1 and day 2 for 3 
assessor 1 were compared to assess intra-observer reliability. The mean of sessions were 4 
consecutively calculated (i.e. mean of measurements 2 and 3, mean of measurements 2, 3 and 5 
4 etc.) and compared either across day 1 and 2 for assessor 1. This was undertaken to identify 6 
the number of individual TPD measurements needed within each TPD assessment to establish 7 
a stable result within a clinically reasonable timeframe for a single assessor. 8 
 9 
A second assessor (either DK or UW) carried out the TPD protocol on day 1 with each 10 
participant immediately after assessor 1 had completed testing. Results between assessor 1 11 
and 2 were compared to assess inter-observer reliability. Again the mean of sessions were 12 
consecutively calculated (i.e. mean of tests 2 and 3, mean of tests 2, 3 and 4 etc.) and 13 
compared across assessors. This was undertaken to identify the number of individual TPD 14 
measurements needed within each TPD assessment to establish a stable result between raters 15 
within a clinically reasonable timeframe. 16 
 17 
All 3 assessors were comparably experienced physiotherapists with more than 15 years 18 
working experience and postgraduate specialisation in Manual Therapy (IFOMPT degree). 19 
KE had over 50 hours experience completing the TPD over the previous year period. UW and 20 
DK received a 1-day training session prior to beginning the study, conducted by KE. All tests 21 
were performed in treatment rooms in a laboratory-based setting in the Hochschule fuer 22 
Gesundheit, Bochum, Germany. 23 
 24 
 25 
 26 
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Clinical characteristics 1 
The following clinical measures were collected to provide a comprehensive clinical picture of 2 
the participants and were in line with international recommendations regarding core sets of 3 
outcome measures for back pain research [19, 20]: pain intensity (Brief Pain Inventory Short 4 
Form); back related physical Function  (Roland Morris Disability Questionnaire); anxiety and 5 
depression (Hospital Anxiety and Depression Scale); health  related quality of life (Euroquol 6 
5D-3L). All questionnaires existed in a validated German version [21-23]. Demographics 7 
including age, gender, height, weight, Body Mass Index (BMI), duration of symptoms and 8 
working status were also documented. 9 
 10 
Statistical analysis 11 
For the adequate precision of sample estimates of error, Altman  [24] advised the recruitment 12 
of at least 40 participants for an agreement-type study like ours. Fifty-two people expressed 13 
an interest in participating at the outset of the study. Seventeen people withdrew before the 14 
first measurements were obtained or did not meet our inclusion/exclusion criteria resulting in 15 
a final sample size of 35 participants (figure 1). Although this sample size is smaller than the 16 
40 advised by Altman [24], we have reported 95% confidence intervals (95%CI) for the 17 
reliability statistics. These 95%CIs are useful for ascertaining if the precision of estimate 18 
affects the overall inferences that are made.   19 
 20 
The greater the number of consecutive measurements averaged within a protocol period, the 21 
closer the average of these measurements approaches the “true value” [25]. Nevertheless, 22 
clinic time is obviously not exhaustive. Therefore, we examined intra- and inter-observer 23 
reliability for a range of consecutive measurements made within the protocol period. The 24 
mean (SD) systematic bias (and associated 95% confidence interval) between data collected 25 
in repeated protocols and between different assessors was first quantified using a paired t-test. 26 
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Random error within and between assessors’ measurements was quantified with the within-1 
subjects SD (standard error of measurement), coefficient of variation, limits of agreement, and 2 
a random-error only (model 3.1) intra class correlation coefficients (ICC). Correlations which 3 
collapse different components of bias, as well as random error between and within assessors 4 
have been criticized in the literature for obfuscating separate sources of variability [25-27]. 5 
The within-subjects SD was then used as an input in statistical power calculations to estimate 6 
whether the random measurement error was small enough to detect a clinically relevant 7 
change in TPD with a feasible sample size [25, 28]. 8 
 9 
RESULTS 10 
Participant Characteristics 11 
Fifty-two people enquired about the study of which 35 met the inclusion criteria and 12 
consented to participate; and all those who consented to participate completed the study 13 
(figure 1). Of the 35, 20 were employed, 10 retired, 3 had retired early due to back pain, and 2 14 
were on sick leave. The overall average for the intra-observer TPD data was 50.5mm (SD 15 
19.2mm). The average levels of pain severity at time 1 and 2 were 3.6 and 3.5 respectively, 16 
defined as  mild-to-moderate severity [29].The average back related physical function was 17 
7.5, similarly defined as a mild-to-moderate disability [30]. For all participants, the area of 18 
pain included the L5 level. The participant characteristics are detailed in table 1. 19 
  20 
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Figure 1: Flow Chart of Participant Recruitment Process, Assessment for Eligibility, Testing 1 
and Data Analysis 2 
 3 
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Intra-observer reliability 1 
The mean difference between test days 1 and 2 in participants’ levels of reported pain severity 2 
was 0.12 arbitrary units (95% CI: -0.25 to 0.48, p=0.52). The difference in pain interference 3 
scores between day 1 and 2 was 0.53 arbitrary units (95% CI: 0.27 to 0.80, p<0.01). 4 
  5 
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 Table 1: Participant characteristics and clinical measures 1 
 Mean (SDa) Range 
Participant characteristics   
Age (years) 52 (15) 22 - 79 
Sex 12♂ 23♀ NRb 
Height (m) 1.72 (0.1) 1.58 - 2.00 
Weight (kg) 76 (17) 47 - 105 
Body Mass Index (kg/m2) 25 (5) 19 - 35 
Symptom Duration (years) 11 (11) 0.5 - 40 
Clinical measures   
BPIc T1d:   
Pain Severity 3.6 (2.0) 0.0 – 7.3 
Pain Interference 2.6 (2.0) 0.0 – 8.4 
BPI T2e:   
Pain Severity 3.5 (1.9) 0.0 – 6.8 
Pain Interference 2.1 (1.8) 0.0 – 6.9 
RMDQf 7.5 (4.6) 1 – 18 
HADSg:   
Anxiety 5.2 (3.4) 0.0 – 15.0 
Depression 4.5 (3.1) 0.0 – 14.0 
EuroQol:   
Thermometer (%) 65 (21) 30 – 100 
Index Value 0.81 (0.20) 0.18 – 1.00 
Legend: a SD = Standard Deviation, b NR = Not Reported, c BPI= Brief Pain Inventory, d T1 = Session 1,e T2 = Session 
2, f RMDQ = Roland Morris Disability Questionnaire, g HADS = Hospital Anxiety and Depression Scale 
 2 
 3 
The intra-observer reliability statistics for rater 1, and across all fourteen consecutive 4 
measurements within the assessment, are shown in table 2. It was judged that taking the 5 
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average of consecutive measurements 2 to 5 resulted in the optimum trade-off between 1 
measurement stability and the clinic time needed to complete testing. In clinical practice, the 2 
shorter the time required to complete the better. The Bland and Altman plot for the individual 3 
differences between days is shown in figure 2. The reliability appraisal was based on the 4 
reasoning that for the mean of 2 to 5 measurements the systematic bias was less than 5mm 5 
(the resolution of the measurement procedure) and the random error began to plateau with 6 
further measurements resulting in minimal reductions in error in relation to the measurement 7 
resolution. The 2-5 consecutive measurements took approximately 5 min to obtain with each 8 
subsequent measure adding approximately 1 min for those participants with the poorest TPD 9 
ability. 10 
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Table 2: Intra-observer reliability 1 
Number of tests 2 2 to 3 2 to 4 2 to 5 2 to 6 2 to 7 2 to 8 2 to 9 2 to 10 2 to 11 2 to 12 2 to 13 2 to 14 
Mean session difference  3.4 3.6 5.5 4.0 3.9 3.4 2.7 1.9 1.3 1.3 0.6 0.4 0.3 
SDa of session differences 17.7 12.8 11.5 10.6 11.4 11.3 11.0 10.8 10.8 10.4 9.8 10.5 10.1 
Within-subjects SD (SEMb) 12.5 9.0 8.1 7.5 8.1 8.0 7.8 7.6 7.6 7.4 7.0 7.4 7.2 
Coefficient of variation (%)  24.0 17.7 16.1 14.9 16.1 16.1 15.6 15.4 15.6 15.1 14.3 15.3 14.7 
Limits of agreement  34.8 25.1 22.5 20.8 22.4 22.2 21.5 21.1 21.1 20.4 19.3 20.6 19.8 
ICCc 0.65 0.80 0.81 0.85 0.82 0.82 0.83 0.83 0.83 0.84 0.85 0.83 0.85 
Legend: Intra-observer reliability data for day 1 and 2 for rater 1 for 14 test repetitions with test 1 excluded as it was considered a practice test. The 2 
values are based upon the cumulative test scores; aSD = Standard Deviation, bSEM = Standard error of measurement, c Intra class correlation 3 
coefficient 4 
 5 
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Figure 2: The Limits of Agreement for intra-observer reliability 1 
 2 
Legend 2: For intra-observer reliability, test-retest differences are plotted against the pooled 3 
means for two sessions for measurement repetitions 2-5. Mean session differences (systematic 4 
bias) are displayed by solid lines and limits of agreement by dashed lines. 5 
 6 
Inter-observer reliability 7 
The inter-observer reliability statistics between rater 1 and 2 across all fourteen measurements 8 
are shown in table 3. The data for the two second raters were pooled as the inter-observer 9 
reliability between rater 1 and both raters 2 and 3 were similar. Using the same reliability 10 
criteria as above, it was judged that averaging the 2nd to 9th consecutive measurements 11 
resulted in the optimum trade-off between measurement stability and the time needed to 12 
complete testing. The Bland and Altman plot for these data is shown in figure 3. The 13 
systematic bias was less than one unit of resolution (5mm) regardless of the number of 14 
consecutive measurements. 15 
 16 
 17 
 18 
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Table 3: Inter-observer reliability 1 
Number of tests 2 2 to 3 2 to 4 2 to 5 2 to 6 2 to 7 2 to 8 2 to 9 2 to 10 2 to 11 2 to 12 2 to 13 2 to 14 
Mean session difference  3.8 2.2 2.0 1.3 1.4 0.9 0.6 -0.1 -0.8 -1.0 -1.8 -2.1 -2.2 
SD of session differences 22.4 18.8 16.0 15.4 14.6 13.3 13.2 12.8 13.1 13.2 13.3 13.0 13.0 
Within-subjects SDa (SEMb) 15.8 12.8 10.9 10.5 10.3 9.3 9.0 8.6 8.7 8.7 8.7 8.6 8.3 
Coefficient of variation (%)  29.9 23.9 20.4 19.5 19.5 17.8 17.3 16.7 17.1 17.2 17.3 17.0 16.5 
Limits of agreement 43.8 35.4 30.3 29.0 28.6 25.9 24.9 23.7 24.0 24.2 24.2 23.7 23.0 
ICCc 0.30 0.53 0.66 0.70 0.70 0.74 0.75 0.76 0.75 0.74 0.74 0.75 0.77 
Legend: Inter-observer reliability data for observer 1 and observer 2 for 14 consecutive measurements with test 1 excluded as it was considered a 2 
practice test. The values are based upon the cumulative measurement scores. The values for rater 2 are the combined values for DK who measured 3 
22 of the participants and UW who measured 13 of the participants. Data for both 2nd raters were sufficiently similar with respect to reliability with 4 
rater 1 to allow pooling of the data; aSD = Standard Deviation, bSEM = Standard error of measurement, cICC= Intra class correlation coefficient  5 
 6 
 7 
 8 
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Figure 3: The limits of agreement for inter-observer reliability 1 
 2 
Legend 3: For inter-observer reliability, the differences from rater 1 and the pooled 3 
differences for rater 2 are plotted against the pooled means for measurement repetition 2-9. 4 
Mean session differences (systematic bias) are displayed by solid lines and limits of 5 
agreement by dashed lines. 6 
 7 
Discussion 8 
The overarching aim of this study was to develop and quantify the intra- and inter-observer 9 
reliability of a novel lower back TPD assessment protocol, which minimises subjective 10 
clinical judgement, in patients with NSCLBP. The study had two objectives - to establish: 1. 11 
the minimum number of TPD measurements required within the assessment protocol to 12 
maximise intra-observer reliability whilst minimising the time required to complete the test; 13 
and 2. the minimum number of TPD measurements required within the assessment protocol to 14 
maximise inter-observer reliability whilst minimising the time required to complete the test? 15 
 16 
Five measurements (with the first used as a practice trial only and not used to calculate the 17 
mean) was identified as the minimum number of TPD measurements required within the TPD 18 
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assessment protocol to maximise intra-observer reliability whilst minimising the time required 1 
to complete the test (approximately 5 minutes).  Nine measurements (with the first used as a 2 
practice trial only and not used to calculate the mean) was identified as the minimum number 3 
of TPD measurements required within the TPD assessment protocol to maximise inter-4 
observer reliability whilst minimising the time required to complete the test (approximately 9 5 
minutes). 6 
 7 
Only one previous study has investigated the intra- and inter-observer reliability of the TPD 8 
for the lower back  [14]. In this study, 28 clinicians assessed the TPD of the lower back in 28 9 
healthy young adults. The mean TPD reported was 55.5mm (SD 12.7mm) with an intra-10 
observer ICC of 0.81 and inter-observer ICC 0.86; and an intra-observer limits of agreement 11 
of (mean difference [lower limit to upper limit]) 0.6mm [-14.1 to 15.4] and an inter-observer 12 
reliability limits of agreement of (1.9mm [-19.0 to 22.8]). In our study, the mean TPD 13 
reported was 50.5mm (SD 19.2mm) with an intra-observer ICC of 0.85 and inter-observer 14 
ICC 0.76; and an intra-observer limits of agreement of (mean difference [lower limit to upper 15 
limit]) 4.0mm [-16.8 to 24.8] and inter-observer reliability limits of agreement of (-0.1mm [-16 
23.8 to 23.7]). Broadly, the level of systematic error and the ICCs were similar between 17 
studies though our study had slightly wider limits of agreement. This is likely due to the 18 
inherent greater variability that would be expected in participants with low back pain 19 
compared with healthy participants.  20 
 21 
In a meta-analysis, Catley et al [31] indicated that a minimal clinically important difference in 22 
TPD between NSCLBP patients and healthy controls is 11.7 mm (26%). Using these values as 23 
a basis for a power estimation and our intra-observer reliability within-subjects SD of 7.5 mm, 24 
it can be estimated that 11 participants would be required for a future single arm pre-post 25 
study (two-tailed P<0.05, statistical power = 90%). We also estimate that 44 participants (22 26 
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in each study arm) would be required for a future two-arm randomised controlled trial, which 1 
is a reasonably achievable sample size within the musculoskeletal rehabilitation research 2 
context. Hence, our TPD assessment protocol can be seen as possessing acceptable intra-3 
observer reliability as a measure of tactile acuity for research purposes. 4 
 5 
Whether this measure is sufficiently reliable to detect change on an individual patient basis 6 
within a clinical setting is less clear. The SEM (or typical error) identified in our study was 7 
7.5mm, which is below the MCID of 11.7mm in the literature. Nevertheless, with 95% limits 8 
of agreement of ±20.8 mm, it can be estimated that an individual back pain patient could 9 
change, in a worst scenario, by as much as 20.8 mm due to normal variation with this 10 
measure. This questions its usefulness in clinical practice, based on the assumption that 11.7 11 
mm is a clinically relevant change. This minimum clinically important difference (MCID) 12 
was estimated from a systematic review comparing individuals with back pain to healthy 13 
controls [15] rather than from a formal estimation of what is a clinically relevant 14 
improvement in patients with back pain. Further work needs to be undertaken to establish the 15 
MCID for back pain patients before firm conclusions can be made about the reliability of our 16 
TPD assessment protocol. Reliability decisions are inherently contingent on the magnitude of 17 
the MCID [25]. 18 
 19 
It has previously been identified that the need for assessor judgement to quantify the exact 20 
TPD in previous protocols has introduced considerable capacity for bias [14]. This study is 21 
the first to present a detailed protocol which eliminates that judgement. While it is not 22 
possible from our data to examine the effect this judgement elimination has had on reliability, 23 
it is reasonable to suggest that it will help to reduce bias. It would be interesting to compare 24 
our TPD protocol with previous protocols that did require assessor judgement to investigate 25 
what effect, if any, assessor judgment has on TPD reliability in the lower back region. 26 
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Clinical Implications 1 
The implications of the higher inter-rater reliability compared with the intra-rater reliability 2 
are that fewer measurements are needed when 1 clinician is treating and monitoring the same 3 
patient, than when test results from more than one clinician are being used. Our findings 4 
indicate that the mean of 5 TPD measurements (with the first considered a practice and not 5 
used to calculate the mean) provided the optimum balance of intra-observer reliability aspects 6 
and practical duration of testing with one clinician. For two clinicians, we identified 9 7 
measurements (with the first considered a practice and not used to calculate the mean) as the 8 
optimum balance of inter-observer reliability aspects and duration of testing. These figures 9 
should be interpreted cautiously in light of the limitations outlined below. 10 
 11 
Strengths and limitations 12 
One limitation in all measurement studies is sample size and, although 52 participants were 13 
contacted initially to take part, our final sample size for analysis was slightly lower than 14 
established recommendations of 40 participants [24]. This recommendation was based on the 15 
adequate precision of estimate of a sample SD. Precision of statistical estimates is indicated 16 
by the 95%CIs. It can be seen in table 4 that these are sufficiently narrow not to alter our 17 
conclusions that the assessment protocol is useful for research but unclear in terms of 18 
reliability of clinical decisions made on individual patients. Our participant sample size is also 19 
somewhat larger than those in other related studies [14, 32, 33]. 20 
 21 
 22 
 23 
 24 
 25 
 26 
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Table 4: Intra- and Inter-observer reliability for the recommended number of test repetitions  1 
 Intra-observer Inter-observer 
Number of tests 2 to 5 2 to 5 2 to 9 
Mean session difference (95% CI) 4.0 (0.49-7.51) 1.3 (-3.84-6.34) -0.1(-4.07-3.96) 
SDa of session differences 10.6 (8.6-13.9) 15.4 (12.5-20.2) 12.8 (10.4-16.8) 
Within-subjects SD (SEMb) 7.5 (6.1-9.8) 10.5 (8.8-14.2) 8.6 (7.4-11.9) 
Coefficient of variation (%)  14.9 (12.1-19.4) 19.5 (16.4-26.5) 16.7 (14.4-23.2) 
Limits of agreement 20.8 (16.9-27.2) 29.0 (24.5-39.6) 23.7 (20.4-32.9) 
ICCc (95% CId) 0.85 (0.72-0.92) 0.70 (0.48-0.84) 0.76 (0.57-0.87) 
Legend: Intra-observer reliability data for day 1 and 2 for rater 1 for 5 measurements with 2 
measurement 1 excluded as it was considered a practice measurement. Inter-observer 3 
reliability data for rater 1 and rater 2 (pooled) for 5 and 9 measurements with measurement 1 4 
excluded respectively. The values are based upon the cumulative test scores. The values for 5 
the 95% Confidence Intervals were calculated according to the recommended method by Zar 6 
[34]; aSD = Standard Deviation, bSEM = Standard error of measurement, cICC= Intra class 7 
correlation coefficient, dCI = Confidence Interval 8 
 9 
One practical limitation of our assessment protocol is that it is carried out in prone lying. 10 
While this in line with other protocols, there is the possibility that for some people with back 11 
pain this may be uncomfortable, which could affect the practicality of testing. Future studies 12 
could be carried out to investigate the measurement properties of this assessment protocol in 13 
sitting. 14 
Because of our limited number of assessors and the fact that they were experienced in the use 15 
of the protocol, the findings of the present study should not be directly generalized to any 16 
other assessor using the same protocol. That will require further work with a larger number of 17 
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assessors. Also, all of our assessors were experienced and so we cannot comment on the 1 
influence of experience. That said, a previous study has suggested that this factor is of limited 2 
importance [14].  3 
In addition, a further limitation could constitute the use of catch trials. We used catch trials in 4 
keeping with previous protocols [12, 17, 35] in order to account for potential effects of 5 
participants guessing. However, patients may be more likely to report the application of a 6 
stimuli after a catch trial as ‘two points’ simply because it feels different (e.g. duller or 7 
coarser) from “one point” but not because of any perceived difference in spatial acuity [36]. 8 
Thus the use of catch trials could artificially lower a patient’s TPD. This may explain why the 9 
TPD measurements reported in our study are lower than those reported by others [15].  10 
Further work could compare the current assessment protocol to another not using catch trials 11 
or employing them differently to weigh up the effects of these catch trials.  12 
The primary strength of this study was the comprehensive range of statistical estimates used 13 
for quantifying the systematic and random changes that can occur in a reliability study [25]. 14 
We concentrated on absolute indicators of reliability such as the within-subjects SD in order 15 
to arrive at our conclusions, especially in terms of extrapolating how the degree of reliability 16 
might impact on future research. Standard procedures for quantifying systematic bias tend to 17 
include the reporting of ICCs. However, in samples with large heterogeneity, a high ICC 18 
might obfuscate substantial and clinically relevant random error [37]. It also does not make 19 
sense to use a type of ICC which combines systematic and random errors into a single value, 20 
because the solutions to reducing systematic and random errors can be very different [26].  21 
 22 
Another strength of the present study constituted the TPD focus on the population of patients 23 
with NSCLBP. As mentioned earlier, the TPD reliability data in a young and healthy 24 
population displayed a large variability [14]. With the expectation of an even greater 25 
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heterogeneity in a population with back pain, here was a need to specifically look at reliability 1 
of the test in this population. 2 
 3 
A final strength of this study was that the participants were clinically stable between 4 
assessment times 1 and 2. While there was a statistically significant improvement in pain 5 
interference between time 1 and 2 this difference was lower than 1 unit on the BPI, which is 6 
not considered to be clinically relevant. [38]. Such stability between measures is an important 7 
methodological issue in reliability studies [39]. 8 
 9 
Conclusion 10 
This study presented data on the development and reliability assessment of a novel TPD 11 
assessment protocol for the lower back. The protocol attempted to overcome previously noted 12 
limitations of TPD measurement protocols that require assessor judgement. This study found 13 
that five measurements (with the first used as a practice trial only and not used to calculate the 14 
average) was the minimum number of TPD measurements required within the assessment 15 
TPD protocol to maximise intra-observer reliability whilst minimising the time required to 16 
complete the assessment. Additionally, nine measurements (with the first used as a practice 17 
trial only and not used to calculate the average) should be used as the minimum number of 18 
TPD measurements within the assessment protocol to maximise inter-observer reliability 19 
whilst minimising the time required to complete the assessment. The protocol described 20 
demonstrates a level of intra-observer reliability sufficient for research purposes. However, it 21 
is unclear, as yet, whether the level of reliability is sufficient for individual patient 22 
measurements in clinical practice. 23 
 24 
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